image
Healthcare - Biotechnology - NASDAQ - US
$ 0.4251
-2.8 %
$ 126 M
Market Cap
-0.33
P/E
Price Target Average
1135.00%
Revenue Forecast Estimate
--29.29%
EBIT Estimate
98.83%
Net Income Estimate
44.02%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Lyell Immunopharma, Inc.
image
Wall Street analysts predict an average 1-year price target for LYEL of $5.25 , with forecasts ranging from a low of $1 to a high of $12 .
LYEL Lowest Price Target Wall Street Target
1 USD 135.24%
LYEL Average Price Target Wall Street Target
5.25 USD 1135.00%
LYEL Highest Price Target Wall Street Target
12 USD 2722.87%
Price
Max Price Target
Min Price Target
Average Price Target
121210108866442200Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart LYEL

image
$90.0m$90.0m$80.0m$80.0m$70.0m$70.0m$60.0m$60.0m$50.0m$50.0m$40.0m$40.0m$30.0m$30.0m$20.0m$20.0m$10.0m$10.0m$0.0$0.020212021202220222023202320242024202520252026202620272027
EBIT FORECAST

EBIT Forecast Chart LYEL

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)20212021202220222023202320242024202520252026202620272027
NET INCOME FORECAST

Net Income Chart LYEL

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)($350.0m)($350.0m)($400.0m)($400.0m)20212021202220222023202320242024202520252026202620272027